Articles By Jack Cush, MD
Mourning the Loss of NIAMS Director Stephen Katz, MD, PhD
The following tribute to the late Dr. Steven Katz appeared on the NIH website.
Read Article
RheumNow Podcast – Rheumatologist Salaries (12.21.18)
Dr. Jack Cush reviews the news from RheumNow for the week ending 12/21/18.
Read Article
Zolendronate Protects Against Fracture in Osteopenia
The NEJM reports that the use of zoledronate significantly reduces the risk of nonvertebral or vertebral fragility fractures in women with osteopenia.
Read Article
Nailfold Videocapillaroscopy in Dermatomyositis
A study of nailfold videocapillaroscopy (NVC) in patients with idiopathic inflammatory myopathies (IIMs) finds abnormalities in more than half of patients suggesting this could be a useful clinical tool in diagnosing and managing patients with IIM.
Read Article
H2H: Ixekizumab vs. Adalimumab in Psoriatic Arthritis
Lilly has issued an advanced press release on its SPIRIT-H2H trial, wherein ixekizumab (Taltz) was shown to be more effective than than adalimumab (Humira) in a 24 week psoriatic arthritis study.
Read Article
Rising Physician Exclusion from Medicare and Medicaid
JAMA Network Open has published that an increasing number of physicians are being excluded from Medicare and other forms of public insurance.
Read Article
RheumNow Podcast – Vasculitis and Strange Bedfellows (12.14.18)
Dr. Jack Cush reviews the news from the past week on RheumNow.com.
Read Article
CDC Top 15 Most Common Opioid Overdose Drugs
The Dec. 12 issue of the National Vital Statistics Reports from the U.S. Centers for Disease Control and Prevention reports that the most commonly abused drugs causing drug overdose deaths (between 2011-2016) include fentanyl, heroin, oxycodone, and cocaine.
Read Article
Psoriatic Arthritis Does Not Add to Pregnancy Problems
When psoriatic arthritis (PsA) patients become pregnant, they do not have more infertility or adverse pregnancy outcomes compared to healthy controls.
Read Article
No End in Sight for the Shingrix Vaccine Shortage
There is a national shortage of a new shingles vaccine, Shingrix, which is a problem for those who want to start the vaccine and those seeking to receive their second and final injection.
Read Article
